EUVIMEDEUVIMED entdecken
Crossref

COVID‐19 Vaccine Response in Pediatric Oncology Patients

Brittni Kam iD, Yiwen Wang, FeiFei Qin, Adrienne H Long, Orly R Klein, Catherine Aftandilian iD

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Brittni Kam und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Stanford University, Stanford, California, USA. Hauptthemen laut MEDLINE: COVID-19, COVID-19 Vaccines, SARS-CoV-2, Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 22 Literaturangaben. Gefördert von: Biostatistics Shared Resource, NIH-funded Stanford Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Pediatric oncology and hematopoietic stem cell transplant (HSCT) patients may fail to mount an appropriate immune response to COVID‐19 vaccinations. The immunologic response to initial SARS‐CoV‐2 vaccination was studied in 93 pediatric patients with hematologic malignancy, solid tumors, or post‐HSCT. The majority of patients who were not receiving chemotherapy showed a positive humoral and cell‐mediated response to COVID‐19 vaccination. In contrast, variable responses to vaccination were seen in patients receiving chemotherapy. Patients with a normal lymphocyte count showed higher rates of seroconversion than their lymphocytopenic counterparts. This report details pediatric oncology and HSCT patients’ immunologic responses to COVID‐19 vaccination during all phases of treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19COVID-19 VaccinesSARS-CoV-2NeoplasmsHematopoietic Stem Cell TransplantationHumansChildMaleFemaleAdolescentChild, PreschoolAntibodies, ViralInfantHematologic NeoplasmsImmunity, Cellular

Stichwörter der Autor:innen

ACE2 | COVID | hematopoietic stem cell transplant | interferon‐gamma response a…

Substanzen

COVID-19 VaccinesAntibodies, Viral

Autor:innen und Institutionen

  • Department of Pediatrics, Stanford University, Stanford, California, USA.
  • Division of Biomedical Informatics Research, Stanford University, Quantitative Sciences Unit, Stanford, California, USA.
  • Division of Hematology/Oncology/Stem Cell Transplant and Regenerative Medicine, Department of Pediatrics, Stanford University, Stanford, California, USA.

ORCID-Profile: Brittni Kam, Catherine Aftandilian

Förderung

  • Biostatistics Shared Resource
  • NIH-funded Stanford Cancer Institute

Zitieren

APA

Kam, B., Wang, Y., Qin, F., Long, A. H., Klein, O. R., & Aftandilian, C. (2025). COVID‐19 Vaccine Response in Pediatric Oncology Patients. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31572

Vancouver

Kam B, Wang Y, Qin F, Long AH, Klein OR, Aftandilian C. COVID‐19 Vaccine Response in Pediatric Oncology Patients. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31572

BibTeX
@article{Kam2025,
  author = {Kam, Brittni and Wang, Yiwen and Qin, FeiFei and Long, Adrienne H and Klein, Orly R and Aftandilian, Catherine},
  title = {COVID‐19 Vaccine Response in Pediatric Oncology Patients},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31572}
}
Kostenlos starten →